← Open Payments lookup

AMANDA MORIARTY: Open Payments

NPI 1306596572 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$700 in 30 payments from 12 companies in 2025. Trend: 2023 $1,112 · 2024 $904 · 2025 $700

Food & beverage: $700
CompanyPaymentsAmount
UCB, Inc.6$192
ABBVIE INC.10$163
Vanda Pharmaceuticals Inc.2$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$44
Neurelis, Inc.2$44
GlaxoSmithKline, LLC.1$35
TOLMAR, INC.1$24
Gilead Sciences, Inc.1$24
Cipher Pharmaceuticals US LLC1$17

Products named: Fintepla, VRAYLAR, FANAPT, CAPLYTA, XIFAXAN, VALTOCO, SHINGRIX, JATENZO.

Industry payments across CA — which companies pay providers there.